Return to content in this issue
Anaphylaxis to Mepolizumab and Omalizumab in a Single Patient: Is Polysorbate the Culprit?
Bergmann KC, Maurer M, Church MK, Zuberbier T
Department of Dermatology and Allergy, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
J Investig Allergol Clin Immunol 2020; Vol 30(4)
: 285-287
doi: 10.18176/jiaci.0492
Key words: Anaphylaxis, Asthma, Mepolizumab, Omalizumab